Sign inJoin waitlistJoin the waitlist

Amanda Paulovich

Director, Clinical Research Proteomics Platform, Brotman Baty Institute for Precision Medicine · University of Washington School of Medicine

Credentials: · · ·

History

Clinical Research Proteomics Platform · University of Washington School of Medicine
Present
University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Dana-Farber Cancer Institute
2003–2004
MIT-Whitehead Center for Genomic Research
2001–2003
Internal Medicine
Massachusetts General Hospital
1998–2000
Genetics, University of Washington
University of Washington School of Medicine
1994–1998
Biological Sciences, Carnegie Mellon University
1984–1988

Research

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
Proceedings of the National Academy of Sciences of the United States of America · 2005 · 42,560 citations
Proteogenomics connects somatic mutations to signalling in breast cancer
Nature · 2016 · 1,323 citations
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma
Nature Biotechnology · 2009 · 842 citations

Andrew Hoofnagle
13 papers · 1 as a resident
ME
Matthew Ellis
7 papers
Michael Gillette
7 papers
Stephen Hewitt
5 papers
Derek Stirewalt
4 papers
Henry Rodriguez
4 papers
Michael Birrer
4 papers
Brian Rood
3 papers
Geoffrey Baird
3 papers
Lewis Chodosh
3 papers
Scott Kaufmann
3 papers
Ajay Gopal
2 papers

Grants

Optimizing Pre-Analytical Variables for Reliable Mass Spectrometry-Based Quantification of Immunomodulatory Proteins in Cerebrospinal Fluid in Pediatric Neuro-Oncology Trials
National Cancer Institute · U01
Contact PI · $845.7K · Fred Hutchinson Cancer Center
2025–2030
Clinical Translation of a NexGen Platform for Quantifying Protein Networks in Human Biospecimens
National Cancer Institute · R01
Contact PI · $6M · Fred Hutchinson Cancer Center
2019–2029
Breast-Cancer Focused Biomarker Characterization Center Employing Targeted Mass Spec Assays in a CLIA Environment
National Cancer Institute · U2C
Contact PI · $3.9M · Fred Hutchinson Cancer Center
2023–2028
Proteogenomic Studies to Understand Mechanisms and Drivers of Resistance to Immunotherapies
National Cancer Institute · U01
Contact PI · $5.6M · Fred Hutchinson Cancer Center
2022–2027